Osher Van De Voorde Investment Management Arrowhead Pharmaceuticals, Inc. Transaction History

Osher Van De Voorde Investment Management

  • $465 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Jul 21, 2020
SELL
$26.12 - $43.27 $13,974 - $23,149
-535 Reduced 5.58%
9,050 $391,000
Q1 2020

Apr 30, 2020
BUY
$20.56 - $63.12 $14,392 - $44,184
700 Added 7.88%
9,585 $276,000
Q2 2019

Aug 13, 2019
BUY
$17.43 - $28.82 $154,865 - $256,065
8,885 New
8,885 $235,000

Others Institutions Holding ARWR

# of Institutions
304
Shares Held
96.2M
Call Options Held
388K
Put Options Held
420K
View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

ARWR Quotes by TradingView
  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.11B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Osher Van De Voorde Investment Management Portfolio

Follow Osher Van De Voorde Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Osher Van De Voorde Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Osher Van De Voorde Investment Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email